Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Pyxis Partners President & CEO Michael Manganiello Featured in Upcoming Warner Bros. Pictures Documentary Highlighting the Legacy of Christopher Reeve


News provided by

Pyxis Partners

Sep 12, 2024, 13:00 ET

Share this article

Share toX

Share this article

Share toX

Visit pyxispartners.co to learn more about Pyxis Partners
Visit pyxispartners.co to learn more about Pyxis Partners

Pyxis Partners Stands with The Christopher & Dana Reeve Foundation in Emphasizing the Importance of Health Research and Striving for Nationwide Health Equity

WASHINGTON, Sept. 12, 2024 /PRNewswire-PRWeb/ -- When Super/Man: The Christopher Reeve Story, a documentary by Warner Bros. Pictures, Words + Pictures, and DC Studios, releases on Sept. 21, 2024, those who have spent any amount of time working with, in, or around the health equity and social impact space in Washington, D.C. will recognize a familiar face featured prominently throughout the film. Pyxis Partners is proud to announce that our President & CEO, Michael Manganiello, appears in the upcoming documentary, which takes an honest look at the remarkable legacy of actor, director, author, and activist, Christopher Reeve, star of four Superman films from 1978-1987, the first DC Studios superhero film, and his profound impact on spinal cord research, disability rights, and the quality of life for all people living with disabilities.

Michael Manganiello, who has been a pioneering advocate for health equity and medical research throughout his career, is highlighted in the documentary for his friendship with Chris and his wife, Dana Reeve, and his significant contributions to the launch of the Christopher Reeve Foundation. After the Foundation merged with the American Paralysis Association, he became the first Senior Vice President of Government Relations. Michael played a crucial role in elevating the organization to national prominence. His leadership was instrumental in the introduction and passage of the Christopher and Dana Reeve Paralysis Act in 2009, a landmark piece of legislation that supported groundbreaking research and quality of life improvements for people living with spinal cord injuries.

"There was no problem that was insurmountable to Christopher Reeve. In many ways, Pyxis Partners is modeled after a lot of lessons that I learned from them (Chris and Dana). They always wanted to leave the world in a better place than they found it." -- Michael Manganiello

Post this

In addition to his legislative achievements, Michael helped raise more than $150 million for the Christopher and Dana Reeve Paralysis Resource Center, which provides essential support and resources for those living with paralysis. Chris, Dana, and Michael's deep commitment to advancing spinal cord research reflected their broader dedication to improving health outcomes and ensuring that cutting-edge medical advancements are accessible to all individuals. Pyxis Partners is proud to help carry on the Reeve family's inspiring legacy, as we help organizations across the country achieve these same victories.

"There was no problem that was insurmountable to Christopher Reeve. He likened his work to that of John F. Kennedy and the Moon Shot," Michael said. "I met Dana when we were waiting tables in Manhattan, and I remember when she first met Chris. They were both passionate, inspiring individuals who elevated everyone around them. In many ways, Pyxis Partners is modeled after a lot of lessons that I learned from them. We always talked about how trust has to be the foundation of any successful relationship, understood the important role that legislative advocacy and lobbying played in advancing health equity and research, and they always wanted to leave the world in a better place than they found it."

Michael's personal health journey has profoundly shaped his perspective on medical research and patient advocacy. Having lived with HIV for more than 35 years, Michael's experience with a life-threatening illness has fueled his passion for advancing health equity and improving access to care. His work at Pyxis Partners includes advancing precision medicine solutions, reducing stigma surrounding the opioid crisis through medication-assisted treatment, and safeguarding reproductive rights. Michael is dedicated to creating innovative, trusted partnerships with key stakeholders to ensure that marginalized communities have a voice and access to essential services.

The documentary also underscores the challenges and triumphs of medical research. Michael has participated in several landmark efforts to advance health research, including co-authoring Back to Basics: HIV/AIDS Advocacy As A Model For Catalyzing Change with Pyxis Partners Principal Ronnie Tepp, a report about how patient advocacy and activism leads to change in how we approach medical research and equity in access to health care. Michael and Ronnie, along with their other co-authors at the Milken Institute's FasterCures Center, sought to highlight the five pillars of patient advocacy that turned HIV from a death sentence to a chronic, manageable illness: getting attention, gathering knowledge & solutions, organized community engagement efforts, holding scientists and government agencies accountable, and identifying true leaders.

"Chris was many things, but I knew him as a fierce advocate," said Ronnie. "I saw first-hand how he worked tirelessly to lift up those around him, create the urgency needed to move research forward, and give hope to so many. I am humbled and grateful for the opportunity to work alongside Michael and the incredible team at Pyxis Partners to advance Chris' vision to improve the quality of life for so many."

After his diagnosis, Michael participated in a clinical trial led by Dr. Anthony Fauci. That clinical trial saved the lives of many people living with HIV, including Michael, and is a testament to the profound impact of dedicated medical research on individual lives. Ultimately, one of the most significant successes of Michael's decades of work in the health equity, advocacy, and health policy communities was his role in giving people living with HIV/AIDS something that they had previously struggled to find: hope.

Both Michael and Pyxis Partners owe a lifelong debt to Christopher and Dana Reeve for inspiring them to continue the fight. We encourage everyone to watch Super/Man: The Christopher Reeve Story, and join us in celebrating Chris and Dana's remarkable story. At Pyxis Partners, we remain steadfast in our commitment to enhancing health equity, access, and affordability. Together, we continue to drive forward in the fight for health equity for every American. We dedicate this work to Chris, our "Superman".

"This documentary beautifully captures the important work that Chris, Dana, and Michael did to advance stem cell research," said Pyxis Partners Principal, Bobby Clark. "At Pyxis Partners, we know from first hand experience that when it comes to health advocacy there is no stronger super power than the voice of the patient."

To learn more about Pyxis Partners or to schedule an interview with Michael, please email [email protected].

Pyxis Partners is a Washington, D.C. based public affairs and social impact firm that advances health equity, access and affordability with a unique expertise in authentic work around equity, diversity and inclusion in the healthcare and clinical trial universe. The firm is defined by developing creative solutions that create pathways to progress which are anchored in a commitment to improving the lives of others and building up communities. Pyxis Partners is certified by the National LGBT Chamber of Commerce and the Department of Small and Local Business Development (DSLBD) as a District of Columbia Certified Business Enterprise (CBE).

Media Contact

Matt Holzapfel, Pyxis Partners, 1 4108044813, [email protected], https://www.pyxispartners.co/

Twitter, LinkedIn

SOURCE Pyxis Partners

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.